The European Union’s drug regulator approved the Novavax Covid-19 vaccine for use in adults
as a highly effective alternative to the mRNA vaccines—for use in adults in the 27-nation bloc on Monday, a major step forward for a fifth coronavirus shot cleared to use in the region as the omicron variant spreads worldwide....
[+]The drug regulator, European Medicines Agency , granted conditional marketing authorization for the two-dose Novavax vaccine, which now just needs confirmation from the EU’s executive commission to start distributing the shots in the region.studies showed the vaccine has about a 90% efficacy rate, and the agency’s human medicines committee determined it “met the EU criteria for efficacy, safety and quality.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Novavax’s Covid-19 Vaccine Recommended for Use in EUNovavax vaccine was recommended for use by the European drug regulator, a major step toward its clearance for use in the European Union
Read more »
EU backs Novavax shot as region's fifth COVID-19 vaccineThe European Union on Monday approved the use of Novavax's COVID-19 vaccine in people 18 years and older, giving a boost to the U.S. biotech after long delays and paving the way for a fifth shot in the region as the Omicron variant spreads quickly.
Read more »
EU set to back Novavax Covid vaccineThe EU's drug regulator will decide Monday whether to approve a Covid jab by Novavax, which uses a more conventional technology that the US biotech firm hopes will reduce vaccine hesitancy.
Read more »
Judge rules against San Diego Unified's COVID-19 vaccine mandateThe court's ruling immediately affects only San Diego Unified, but it could influence challenges to COVID-19 vaccine mandates in other school districts.
Read more »
Data suggest boosters are essential to avoid omicron infection, and Fauci says the best way to protect kids is to make sure adults around them are fully vaccinatedEarly data suggests that only the COVID-19 vaccines developed by Pfizer/BioNTech and Moderna, bolstered by a booster shot, are effective against infection with the new omicron variant.
Read more »